.JPG)
Genoma is one of the leading stem cell treatment centers in the United States, focused on regenerative applications of stem cells for treatments of chronic, degenerative diseases with outstanding results.
Genoma recently teamed up with the Medical Tourism Association (MTA), the global authority in the medical travel industry, obtained its Gold Membership as a key step to expanding its offerings to the international market. In this interview, Genoma talks about the future of stem cell treatments, especially for the global market.
What do you do and how has your experience in the healthcare industry been?
We are a multidisciplinary team specialized in advanced, regenerative medicine and cell therapy with stem cell treatments. Our focus is on treatment and prevention of chronic degenerative diseases (such as diabetes, Alzheimer’s, Parkinsons or, cancer) to provide a better quality of life in our society. We have developed a new form of stem cell therapy for its better function.
Genoma was born with the vision of revolutionizing regenerative medicine and cell therapy. Working to improve the quality of life of our patients through innovative and personalized treatments that regenerate tissues and treat degenerative diseases. Genoma has stood out for its commitment to excellence and empathy.
Each procedure we perform is adapted to the specific needs of our patients, using stem cells and cutting-edge technologies to ensure optimal results. With the mission of restoring vitality to those who need it most, always maintaining a human and professional approach.
How many international patients do you receive per year?
We receive approximately more than 1,300 patients per year from different parts of the world, who seek advanced stem cell treatments for a range of chronic diseases.
What regions or countries do patients come from?
Our patients mostly come from the USA and Latin America, but some of our patients come from Europe as well.
How do you see the future of medical travel?
Our target is based on medical travel. We think the globalization of medicine is a benefit that helps both ways (to both patients and doctors). Medical tourism will allow better medical progress and possibilities to treat different diseases.
What is something unique that you as do a healthcare Business?
We focus on the quality of life of our patients comprehensively. Not only do we offer a purely medical service, but our staff is responsible for providing the necessary follow-up to improve quality of life. This approach is noticeable from the first day in consultation until the last days. We provide personalized monitoring and treatment that empathizes with our patients.
What services do you offer to medical travelers?
We take care of travel recommendations (such as accommodation, tourism, gastronomy among others). We also work with a third-party company that takes care of these logistics.
What medical procedures do you offer?
Some of the services we offer include:
- Direct and indirect genetic therapy: We apply cutting-edge techniques to correct genetic mutations and the regulation of gene expression.
- Advanced cell therapy: Specialized in antitumor and immunomodulatory therapy, our treatments focus on strengthening the immune system and effectively fighting cancer.
- Therapy with stem cells and growth factors and cell signaling: We use stem cells and growth factors to promote tissue regeneration and repair damaged tissues.
Why do you think Better by MTA is so great for the industry?
We have previously worked with MTA. We really like their professionalism and the quality of the service they offer. Better by MTA is set to revolutionize medical travel as it drives seamless financial transactions and offers a one-stop shop for medical travelers to coordinate all their medical travel needs. This is undoubtedly a game changer for the medical travel industry.
